AMN Healthcare Services, Inc. (AMN)

In the past six months, AMN Healthcare Services, Inc.'s stock price has experienced notable movements, underperforming the S&P500 Index by -7.76%. As of early May 2026, shares were trading +8.52% higher than their 200-day moving average. The Q1 2026 earnings announcement on May 7, 2026, reported better-than-expected earnings, with $2.10 EPS, exceeding the consensus estimate by $0.50. The company's revenue for the quarter was $1.38 billion, exceeding the consensus estimate and representing a 99.9% increase year-over-year, driven by labor disruption events and travel nurse revenue growth. Following these positive results, AMN Healthcare Services' shares gapped up and hit a new 52-week high, and analyst sentiment has turned more positive.

Demand for AMN Healthcare Services, Inc.'s products and services can exhibit seasonality, influenced by various factors within the healthcare industry. Demand for staffing services is sensitive to changes in economic activity. AMN partners with large hospital systems to manage seasonal volume swings, particularly in Sun Belt states, which experience increased demand due to retiree inflows and higher care needs. California also sees elevated demand due to nurse-to-patient ratio mandates. Hospitals utilize temporary healthcare professionals to accommodate increases in hospital admissions, new unit openings, seasonal patient census variations, and staff shortages. Unforeseen events like strikes can also significantly impact demand for AMN's services.

AMN Healthcare Services, Inc. is a leading provider of total talent solutions for healthcare organizations across the United States, operating primarily within the Healthcare Facilities & Services and Healthcare Providers & Services sectors. The company offers a comprehensive suite of staffing and workforce solutions, including temporary and permanent placement of healthcare professionals. Its major products and services are categorized into Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. AMN Healthcare's value proposition lies in its scale, compliance infrastructure, and integrated technology, which drive recurring, high-margin revenue across hospital systems and large healthcare networks. The company has also integrated generative AI to speed clinician matching and reduce time-to-fill for nursing roles.

AMN Healthcare Services, Inc. maintains a nationwide footprint, with operations spanning all 50 U.S. states, serving over 3,000 healthcare facilities. Over 95% of its revenue is generated domestically, with a concentration in high-density urban corridors and Sun Belt states. The company also has physical office locations in California, Florida, and Georgia.

AMN Healthcare Services, Inc. is recognized as a leader in the healthcare staffing industry. In January 2026, President and CEO Cary Grace was named to SIA's 2026 Staffing 100 list. In February 2026, AMN Healthcare was named to Becker's Hospital Review Top 165 Places to Work in Healthcare 2026. In December 2025, AMN Healthcare was named a Modern Healthcare 2025 Best in Business company for Recruiting and Staffing, and President and CEO Cary Grace was named Outstanding Healthcare Executive at DCEO's Excellence in Healthcare Awards. In 2024, the company received the "Best of Staffing Client Satisfaction 2024" award. In 2023, AMN Healthcare was recognized in HRO Baker's Dozen for overall quality and breadth of services in total workforce solutions and as a Healthcare RPO Winner, and Forbes recognized AMN Healthcare among America's Best Temporary Staffing Firms. AMN Healthcare also holds the Gold Seal of Approval™ for Staffing Companies from The Joint Commission.

AMN Healthcare Services, Inc.'s ownership is heavily dominated by institutional investors, who collectively hold a significant majority of the company's shares. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., and Millennium Management Llc, among others. Insider ownership represents a minimal portion of the total shares, typically under 1%. Institutional investors exert significant influence over corporate strategy and board appointments.